Andrew Hykes - Feb 10, 2025 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
President and CEO, Director
Signature
/s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Feb 10, 2025
Transactions value $
$184,569
Form type
4
Date filed
2/12/2025, 04:42 PM
Previous filing
Feb 6, 2025
Next filing
Feb 19, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $69K +161K +32.05% $0.43 664K Feb 10, 2025 Direct
transaction NARI Common Stock Options Exercise $108K +16.7K +2.52% $6.45 681K Feb 10, 2025 Direct
transaction NARI Common Stock Options Exercise $7.64K +16.7K +2.46% $0.46 697K Feb 10, 2025 Direct
holding NARI Common Stock 1.55K Feb 10, 2025 By Child 1
holding NARI Common Stock 1.55K Feb 10, 2025 By Child 2
holding NARI Common Stock 1.55K Feb 10, 2025 By Child 3
holding NARI Common Stock 1K Feb 10, 2025 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Options (Right to Buy) Options Exercise $0 -161K -100% $0.00 0 Feb 10, 2025 Common Stock 161K $0.43 Direct F1
transaction NARI Stock Option Options Exercise $0 -16.7K -100% $0.00 0 Feb 10, 2025 Common Stock 16.7K $6.45 Direct F2
transaction NARI Stock Option Options Exercise $0 -16.7K -100% $0.00 0 Feb 10, 2025 Common Stock 16.7K $0.46 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option became fully vested and exercisable as of March 29, 2022.
F2 The option became fully vested and exercisable as of January 1, 2024.
F3 The option became fully vested and exercisable as of January 1, 2023.